Our current newsletter features a great read by our Partner Matt Dumas on the changing face of patient engagement driven by clients Linkwell Health and Jiff, and an article by Associate Liam Gallagher discussing the shift in clinical roles within healthcare and organizations such as GoHealth that are leading that charge. Hope you enjoy!

Oxeon Newsletter >>

Click here to read Oxeon's quarterly newsletter

Oxeon is pleased to announce Gwen O'Keefe, previously of Group Health Cooperative, as Chief Medical Officer of Qliance. An Oxeon portfolio investment, Qliance is a leading healthcare organization giving patients convenient, affordable access to highly skilled doctors, nurses and healthcare teams for primary, preventative and urgent care service. Qliance is additionally funded by Second Avenue Partners, New Atlantic Ventures, Clear Fir Partners, Bezos Expeditions, MSD Capital and others.

Qliance >>

Oxeon places Gwen O'Keefe as Chief Medical Officer at Qliance

Oxeon is excited to announce the placement of Robert Tremain, previously of Aetna, and Rick Cochran, previously of Physicians Health Plan, as Market Presidents with Evolent Health. An Oxeon portfolio investment, Evolent Health is the first provider-led, fully integrated platform for population and health plan management for leading health systems, and is additionally funded by UPMC Health Plan, The Advisory Board Company and TPG Growth.

Evolent Health >>

Oxeon places Robert Tremain and Rick Cochran as Market Presidents with Evolent Health

Oxeon congratulates client and portfolio investment, Iora Health on closing their Series C funding round with $28M from four new investors: Foundation Medical Partners, Rice Management Company, GE Ventures and Khosla Ventures. They join existing investors Fidelity Biosciences, Polaris Partners, .406 Ventures and Tony Hsieh, among others. Iora Health will use the additional financing to fund rapid expansion to continue delivering transformative health care.

Iora Health >>

Iora Health has secured $28M in its Series C funding round

Oxeon is excited to announce the placement of Rick Adam, former founder and CEO of Recondo Technology, as President and Chief Operating Officer of Stanson Health. Stanson Health, an innovative health IT company being spun out of Cedars-Sinai, offers a next-generation clinical decision support system that fully integrates into a provider’s existing EMR in order to yield smarter, real-time decision support at the point of care. Stanson Health is wholly funded by Cedars-Sinai.

Stanson Health >>

Oxeon places Rick Adam as President & Chief Operating Officer at Stanson Health

Oxeon is pleased to announce the placement of Ed Lehman, previously of Cigna Healthcare, as Senior Vice President of Sales with Grand Rounds. Grand Rounds is an Outcomes Management platform that delivers the best healthcare outcomes for employees at the lowest possible cost to employers, and is funded by Greylock Partners, Venrock and Harrison Metal.

Grand Rounds >>

Oxeon places Ed Lehman as Senior Vice President of Sales at Grand Rounds